Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Singapore-based Allozymes operates in Biotechnology Research. It is privately held, and its site is allozymes.com. It holds one address on record, all in Singapore. Headcount on record is 31. Its work is tagged biocatalysis, enzyme Engineering and enzyme Discovery. One Singapore registration (UEN) is a confirmed match. Its latest round on record is Series A, US$15.0M. It is listed alongside eight similar brands, mostly in Biotechnology Research.
UEN201941025E
| ALLOZYMES PTE. LTD. | UEN 201941025E |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Allozymes is a biotechnology company redefining enzyme engineering through its proprietary ultra-high-throughput microfluidic and AI-driven screening platform. By integrating biocatalysis, enzyme discovery, and microfluidic innovation, we accelerate the development of tailored enzymes for biomanufacturing, pharma, and life sciences. With a vision to build the world’s most comprehensive enzyme data library, Allozymes is enabling faster discovery, smarter optimization, and sustainable production across industries.
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
| Rounds | 4 |
|---|---|
| Axis | 2020 to 2026 |
| Series A · 7 Sep 2023 | US$ 15.0M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One Singapore entity on ACRA: ALLOZYMES PTE. LTD. (UEN 201941025E), high confidence.
31 counted staff profiles at January 2026, inside the self-reported 11–50 band.
One address on record, Singapore only. Primary: 79 Science Park Drive, 06-05, Singapore 118264.
Four rounds. Latest 7 September 2023: Series A, US$15,000,000, investors Seventure Partners and Xora Innovation.
Ten tags on the brand's own list, among them Biocatalysis, Enzyme Engineering and Enzyme Discovery.
34 profiles list Allozymes as a peer — 97th percentile in Biotechnology Research. It lists ten peers of its own. Tessa Therapeutics Ltd and NSG BioLabs list it back.